News blog
Akers Biosciences Inc
- BY: Andrew Hore |
- POSTED: 24/11/2009 |
Legal & General has taken advantage of recent share price weakness to take a stake in Akers Biosciences Inc.
Legal & General has bought 6.8m shares, giving it a 5.96% stake in the diagnostics company.
Southridge Capital Management (Brittany Capital) has cut its stake from 25.94% to 13.79%.
Weak trading at Akers has knocked the share price, although it has started to recover in recent weeks.
At 14.25p a share, Akers is valued at £16.2m.
© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|